Video
Catch up on the exciting Aesthetic Society accomplishments and advances that took place in 2023.
The Aesthetic Society Year in Review 2023/2024
Related Articles
This is my last newsletter as President of The Aesthetic Foundation, and it has been a busy and productive year. Our core mission is to support research that is relevant to practicing plastic surgeons and improve the safety and effectiveness of the procedures that we offer to our patients.
In this month’s update, Dr. Tracy Pfeifer highlights all things The Aesthetic MEET, reflecting on her time as president and how she got involved in The Aesthetic Society, and check out the blooper reel at the end!
In this month’s update, Dr. Tracy Pfeifer highlights all our webinars, like Master Class and AlliedPro Forum, all the travels from New York to Florida, recapping the Facial and Rhinoplasty Symposium and the upcoming The MEET 2026 in Boston!
For this post hoc analysis, the authors extracted and analyzed data from the BLESS III study to determine whether there were variances in the effectiveness and safety of letibotulinumtoxinA for treating vertical glabellar lines between the broader female study population and a group of female participants aged 35 to 50.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”